Further, high levels of NOTCH and JAG1 were detected in tumors with poor-prognosis features and found associated with shorter survival compared to breast cancer patients with low tumor levels of NOTCH1 and JAG1 [7–9]. This evidence concerns the gene JAG1 and neoplasm.